PEGASUS Trademark

Trademark Overview


On Tuesday, March 9, 2021, a trademark application was filed for PEGASUS with the United States Patent and Trademark Office. The USPTO has given the PEGASUS trademark a serial number of 79309601. The federal status of this trademark filing is REGISTERED as of Tuesday, June 28, 2022. This trademark is owned by femtos GmbH. The PEGASUS trademark is filed in the Medical Instrument Products category with the following description:

Stents; drug-coated stents, in particular biocompatible coated stents; neurovascular stents; drug-coated neurovascular stents, in particular biocompatible coated neurovascular stents; medical implants comprising natural, non-living and artificial materials for the treatment of aneurysms, in particular of cerebral aneurysms; medical implants comprising natural, non-living and artificial materials for insertion into aneurysms, in particular into cerebral aneurysms; medical occlusion devices, namely, medical implants comprising natural, non-living and artificial materials for closing cerebral blood vessels or cerebral vessel wall cavities; flow diverters, namely, medical implants comprising natural, non-living and artificial materials for influencing the neurovascular blood flow; Medical devices for the treatment of vascular disorders and events, namely, for the removing of thrombi, in particular of cerebral thrombi; medical devices for the treatment of a cerebral vasospasm; medical impla...
pegasus

General Information


Serial Number79309601
Word MarkPEGASUS
Filing DateTuesday, March 9, 2021
Status700 - REGISTERED
Status DateTuesday, June 28, 2022
Registration Number6770058
Registration DateTuesday, June 28, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 12, 2022

Trademark Statements


Goods and ServicesStents; drug-coated stents, in particular biocompatible coated stents; neurovascular stents; drug-coated neurovascular stents, in particular biocompatible coated neurovascular stents; medical implants comprising natural, non-living and artificial materials for the treatment of aneurysms, in particular of cerebral aneurysms; medical implants comprising natural, non-living and artificial materials for insertion into aneurysms, in particular into cerebral aneurysms; medical occlusion devices, namely, medical implants comprising natural, non-living and artificial materials for closing cerebral blood vessels or cerebral vessel wall cavities; flow diverters, namely, medical implants comprising natural, non-living and artificial materials for influencing the neurovascular blood flow; Medical devices for the treatment of vascular disorders and events, namely, for the removing of thrombi, in particular of cerebral thrombi; medical devices for the treatment of a cerebral vasospasm; medical implants comprising natural, non-living and artificial materials for the treatment of a cerebral vasospasm; neurovascular percutaneous transluminal angioplasty (PTA) balloon catheters, including drug-coated neurovascular percutaneous transluminal angioplasty (PTA) balloon catheters; medical guide wires; percutaneous insertion kits comprised of medical needles and introducers for the afore-mentioned goods of this class

Classification Information


International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, April 30, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party Namefemtos GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressDE

Party Namefemtos GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party Namefemtos GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, October 5, 2022FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, October 5, 2022FINAL DISPOSITION PROCESSED
Wednesday, September 28, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 28, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, June 28, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, April 12, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 12, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 23, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, March 8, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 7, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, March 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 29, 2021REFUSAL PROCESSED BY IB
Monday, November 8, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, November 8, 2021REFUSAL PROCESSED BY MPU
Saturday, October 9, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, October 8, 2021NON-FINAL ACTION WRITTEN
Monday, October 4, 2021ASSIGNED TO EXAMINER
Tuesday, May 4, 2021APPLICATION FILING RECEIPT MAILED
Friday, April 30, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 29, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB